about
Targeting CDK4 and CDK6: From Discovery to TherapyRestoration of tumor suppressor functions by small-molecule inhibitorsMitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functionsFirst-in-Class CDK4/6 Inhibitor Palbociclib Could Usher in a New Wave of Combination Therapies for HR+, HER2- Breast Cancer.Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cellsCell cycle proteins as promising targets in cancer therapyCDK6 is a regulator of stem cells "Egr" to wake upGastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis.
P2860
Q28082912-37352589-48A0-4A93-A02F-FBE0523103F8Q28830520-2FABF835-E55A-4DE5-A6CD-23273838A84EQ35549264-1F24A947-9436-4006-AFBD-FA232EA373A3Q35896455-6FC4514D-0E67-47B6-84B5-58ACCDD82ABEQ37171068-E52A0900-9A33-499A-8FAF-5692B20D8637Q37693690-C89A4410-A9A1-44B9-881C-ED9F770079DCQ42154652-0210BED4-8958-41A1-BDEB-F6FE23ECC1E9Q43281043-F862BFC3-0D35-4F3D-9436-55C89A619E46
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
The cancer drug that almost wasn't.
@en
The cancer drug that almost wasn't.
@nl
type
label
The cancer drug that almost wasn't.
@en
The cancer drug that almost wasn't.
@nl
prefLabel
The cancer drug that almost wasn't.
@en
The cancer drug that almost wasn't.
@nl
P1433
P1476
The cancer drug that almost wasn't.
@en
P2093
Ken Garber
P304
P356
10.1126/SCIENCE.345.6199.865
P407
P577
2014-08-01T00:00:00Z